Susquehanna International Group’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Susquehanna International Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,200	Closed	-$202K	–	10466
2016 Q4	$202K	Sell	4,200 -8,550	-67%	-$403K	﹤0.01%	8640
2016 Q3	$539K	Buy	12,750 +250	+2%	+$11.5K	﹤0.01%	5936
2016 Q2	$809K	Buy	+12,500	New	+$769K	﹤0.01%	5270
2016 Q1	–	Sell	-6,650	Closed	-$273K	–	9987
2015 Q4	$273K	Sell	6,650 -5,900	-47%	-$290K	﹤0.01%	7871
2015 Q3	$823K	Buy	+12,550	New	+$570K	﹤0.01%	6149

Other funds holding ZBIO

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's ZBIO Position: Q1 2020 in Review

Susquehanna International Group sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q1 2020, closing a stake of 20,322 shares — an estimated $186K sold.

Susquehanna International Group first reported a position in ZBIO in Q1 2016 and held it in 12 quarters. The position peaked at $944K in Q1 2016. 1 fund tracked by Wall St. Rank holds ZBIO as of Q1 2020.

Susquehanna International Group reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
Susquehanna International Group sold 20,322 ProShares UltraPro Short NASDAQ Biotechnology shares in Q1 2020, an estimated $186K.
Susquehanna International Group first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q1 2016 and held it in 12 quarters.
Susquehanna International Group's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $944K in Q1 2016.
1 fund tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.